Request Trial
vchal
vchal / iStockphoto.com
11 July 2017Americas

Broad Institute enters talks for CRISPR licensing pool

The Broad Institute of MIT and Harvard has announced that it has entered talks to create a worldwide licensing pool for CRISPR/Cas9 patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Natera and a rival draw the line under five-year fight
27 February 2026   The companies have agreed to dismiss their long-running patent fight over tumour-informed liquid biopsy technology, closing a high-stakes chapter in the fast-growing MRD testing market—while leaving the door open to future claims.
Americas
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
26 February 2026   As the US Supreme Court prepares to hear arguments in the Hikma and Amarin dispute, the case has drawn a broad coalition of industry support—including the US government and a co-author of the Hatch-Waxman Act itself.
Americas
Eli Lilly escapes $278m payout in biotech licensing dispute
26 February 2026   In a decision with implications for biotechnology licensing and pharmaceutical manufacturing, the Ninth Circuit has rejected a ‘sweeping’ royalty trigger from a lower court.


Editor's picks

SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
Americas
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
26 February 2026

Editor's picks

Americas
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
26 February 2026

More features

Natera and a rival draw the line under five-year fight
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
Eli Lilly escapes $278m payout in biotech licensing dispute
Novo battles for GLP-1 leadership with fresh lawsuit and slashed prices
Wiggin’s new litigation partner deepens ‘technically complex’ offer
Could everyday hospital equipment be the next defence against counterfeit medicines?
BioNTech fires shots at Moderna's next-generation vaccine
Mintz gains ex-Winston & Strawn partner and ITC expert